JP2024506067A5 - - Google Patents
Info
- Publication number
- JP2024506067A5 JP2024506067A5 JP2023548215A JP2023548215A JP2024506067A5 JP 2024506067 A5 JP2024506067 A5 JP 2024506067A5 JP 2023548215 A JP2023548215 A JP 2023548215A JP 2023548215 A JP2023548215 A JP 2023548215A JP 2024506067 A5 JP2024506067 A5 JP 2024506067A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- stem
- group
- modified
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163147933P | 2021-02-10 | 2021-02-10 | |
| US63/147,933 | 2021-02-10 | ||
| US202163236828P | 2021-08-25 | 2021-08-25 | |
| US63/236,828 | 2021-08-25 | ||
| PCT/AU2022/050075 WO2022170384A1 (en) | 2021-02-10 | 2022-02-09 | Methods and compositions for generating stem cell-derived immune cells with enhanced function |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024506067A JP2024506067A (ja) | 2024-02-08 |
| JP2024506067A5 true JP2024506067A5 (cg-RX-API-DMAC10.html) | 2025-02-18 |
Family
ID=82838866
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023548215A Pending JP2024506067A (ja) | 2021-02-10 | 2022-02-09 | 増強された機能を有する幹細胞由来免疫細胞を生成するための方法および組成物 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240117311A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP4291660A4 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2024506067A (cg-RX-API-DMAC10.html) |
| KR (1) | KR20240004245A (cg-RX-API-DMAC10.html) |
| AU (1) | AU2022220754A1 (cg-RX-API-DMAC10.html) |
| CA (1) | CA3211013A1 (cg-RX-API-DMAC10.html) |
| WO (1) | WO2022170384A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN119432926B (zh) * | 2024-11-18 | 2025-08-26 | 首都医科大学附属北京儿童医院 | 一种系统性红斑狼疮小鼠模型的构建方法及其应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014039513A2 (en) * | 2012-09-04 | 2014-03-13 | The Trustees Of The University Of Pennsylvania | Inhibition of diacylglycerol kinase to augment adoptive t cell transfer |
| ES2918501T3 (es) * | 2013-12-19 | 2022-07-18 | Novartis Ag | Receptores de antígenos quiméricos de mesotelina humana y usos de los mismos |
| US12012598B2 (en) * | 2016-08-12 | 2024-06-18 | Toolgen Incorporated | Manipulated immunoregulatory element and immunity altered thereby |
| US12275963B2 (en) * | 2017-05-08 | 2025-04-15 | Toolgen Incorporated | Artificially manipulated immune cell |
| CN114127268A (zh) * | 2019-05-02 | 2022-03-01 | 塞利亚德股份公司 | 具有多重化的抑制性rna的细胞 |
| CN115885038A (zh) * | 2020-06-17 | 2023-03-31 | 国立大学法人京都大学 | 表达嵌合抗原受体的免疫活性细胞 |
-
2022
- 2022-02-09 KR KR1020237030745A patent/KR20240004245A/ko active Pending
- 2022-02-09 WO PCT/AU2022/050075 patent/WO2022170384A1/en not_active Ceased
- 2022-02-09 EP EP22751998.0A patent/EP4291660A4/en active Pending
- 2022-02-09 JP JP2023548215A patent/JP2024506067A/ja active Pending
- 2022-02-09 CA CA3211013A patent/CA3211013A1/en active Pending
- 2022-02-09 US US18/276,794 patent/US20240117311A1/en active Pending
- 2022-02-09 AU AU2022220754A patent/AU2022220754A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20230287348A1 (en) | Method for the generation of genetically modified cells | |
| Dickinson et al. | Graft-versus-leukemia effect following hematopoietic stem cell transplantation for leukemia | |
| Yanir et al. | Immune reconstitution after allogeneic haematopoietic cell transplantation: from observational studies to targeted interventions | |
| Lv et al. | Strategies for overcoming bottlenecks in allogeneic CAR-T cell therapy | |
| KR102954207B1 (ko) | 면역요법을 위한 t 세포 내 tgfbr2의 crispr-cas9 편집 방법, 조성물 및 성분 | |
| Yu et al. | Dendritic cell regulation of graft-vs.-host disease: immunostimulation and tolerance | |
| Peng et al. | Natural killer cell memory: progress and implications | |
| Litjens et al. | Potential beneficial effects of cytomegalovirus infection after transplantation | |
| Leung | Use of NK cell activity in cure by transplant | |
| JP2024054194A5 (cg-RX-API-DMAC10.html) | ||
| Berglund et al. | Advances in umbilical cord blood cell therapy: the present and the future | |
| Flahou et al. | Fit-for-all iPSC-derived cell therapies and their evaluation in humanized mice with NK cell immunity | |
| US6586192B1 (en) | Compositions and methods for use in affecting hematopoietic stem cell populations in mammals | |
| Maier et al. | Efficient clinical scale gene modification via zinc finger nuclease–targeted disruption of the HIV co-receptor CCR5 | |
| Della Chiesa et al. | Impact of HCMV infection on NK cell development and function after HSCT | |
| JP2022520402A5 (cg-RX-API-DMAC10.html) | ||
| JP2020505934A5 (cg-RX-API-DMAC10.html) | ||
| Broxmeyer et al. | Cord blood hematopoietic cell transplantation | |
| Drummond et al. | Concise review: telomere biology in normal and leukemic hematopoietic stem cells | |
| Babor et al. | The role of KIR genes and ligands in leukemia surveillance | |
| Mrahleh et al. | Human Wharton’s jelly-derived mesenchymal stromal cells primed by tumor necrosis factor-α and interferon-γ modulate the innate and adaptive immune cells of type 1 diabetic patients | |
| Fang et al. | Unlocking the potential of iPSC-derived immune cells: engineering iNK and iT cells for cutting-edge immunotherapy | |
| Zhang et al. | Adoptive T cell therapy following haploidentical hematopoietic stem cell transplantation | |
| Zhang et al. | Hypoimmunogenic CD19 CAR-NK cells derived from embryonic stem cells suppress the progression of human B-cell malignancies in xenograft animals | |
| Moretta et al. | In vitro evaluation of graft-versus-graft alloreactivity as a tool to identify the predominant cord blood unit before double cord blood transplantation |